A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/465 (2006.01) A61K 9/127 (2006.01)
Patent
CA 2357765
The present invention is referred to the encapsulation of the drug Niflumic acid in liposomes with the purpose to create a new transdermal non-steroidal anti-flammatory formulation. The Niflumic acid as well as its ester derivates, have been encapsulated into liposomes with different lipid formulations in order to achieve the increased effectiveness of the active compound. The liposome suspension, with or without the encapsulated drug has been formulated as a cream and a stability study of the final formulation has followed.
La présente invention concerne l'encapsulation du médicament acide niflumique dans des liposomes dans le but de créer une nouvelle formulation anti-inflammatoire non stéroïdienne et transdermique. L'acide niflumique est ses dérivés esters ont été encapsulés dans les liposomes avec différentes formulations de lipides pour augmenter l'efficacité du composé actif. La suspension de liposomes, avec ou sans le produit encapsulé, a été formulée sous forme de crème. Par ailleurs, une étude de stabilité de la formulation finale a été effectuée.
Demetzos Konstantinos
Georgopoulos Aristidis
Giannisis Georgios
Hatziantoniou Sofia
Kammenou Helen
P.n. Gerolymatos S.a.
Ridout & Maybee Llp
LandOfFree
Liposomic niflumic acid - new transdermal anti-inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposomic niflumic acid - new transdermal anti-inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomic niflumic acid - new transdermal anti-inflammatory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1575065